ErnstR.LengyelMDPhD

Gynecologic Oncology, Minimally Invasive / Endoscopic Surgery

Chairman and Professor Department of Obstetrics and Gynecology, University of Chicago Medicine

Dr. Lengyel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-702-5411

Dr. Lengyel is a Gynecologic Oncologist and Chair of the Department of Ob&Gyn at The University of Chicago. He received his M.D. from the University of Munich and trained in Munich, Stanford and at UCSF. He is board certified in Ob&Gyn and Gyn Oncology.
In addition to his clinical practice, Dr. Lengyel runs an ovarian cancer research laboratory, where he studies the biology of ovarian cancer metastasis and searches for novel drugs for treatment. Dr. Lengyel has an outstanding level of expertise and leadership in the surgical treatment of ovarian cancer and a deep commitment to improving women’s health in general.

University of California (San Francisco)Fellowship, Gynecologic Oncology, 2000 - 2003
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1992

National Academy of Medicine National Academy, 2019
America's Top Doctors Castle Connolly, 2011-2016
Chicago Magazine: Top Doctors Castle Connolly, 2012, 2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Chicago Magazine - Women's Health Castle Connolly, 2011
Super Doctor SuperDoctors.com
Join now to see all

PubMed

Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer.
Hao Huang, Russel Keathley, Ujin Kim, Horacio Cardenas, Ping Xie
NPJ Genomic Medicine. 2024-12-02
1 citations
Molecular changes driving low-grade serous ovarian cancer and implications for treatment.
Lucy Kelliher, Roni Yoeli-Bik, Lisa Schweizer, Ernst Lengyel
International Journal of Gynecological Cancer. 2024-10-07
AI-based automated segmentation for ovarian/adnexal masses and their internal components on ultrasound imaging.
Heather M Whitney, Roni Yoeli-Bik, Jacques S Abramowicz, Li Lan, Hui Li
Journal of Medical Imaging. 2024-07-01

Journal Articles

A 3D Tumor Microenvironment Regulates Cell Proliferation, Peritoneal Growth and Expression Patterns
Ernst Lengyel, MD, ScienceDirect
m6A mRNA Methylation Regulates AKT Activity to Promote the Proliferation and Tumorigenicity of Endometrial Cancer
Ernst Lengyel, MD, Nature

Ernst Lengyel, MD, PhD, Appointed University of Chicago Health System Leader for OB/GYNSeptember 30th, 2024
ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
Upfront HIPEC May up Survival in Ovarian CancerAugust 25th, 2020
Join now to see all

Adaptation Of An Organotypic 3 Dimensional Culture For High-Throughput ScreeningNational Institute Of Neurological Disorders And Stroke2011
Regulation Of Adhesion And Proteolysis In Ovarian CancerNational Cancer Institute2006–2010

Clinical websitehttp://www.uchospitals.edu/specialties/cancer/gynecologic/ovarian/
Research websitehttp://obg.bsd.uchicago.edu/FacultyResearch/lengyellab.htm
Section of Gynecologic Oncology Univ of Chicagohttps://obgyn.uchicago.edu/page/section-gynecologic-oncology